---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-210679"
form_type: "8-K"
ticker: "BNTC"
cik: "0001808898"
company_name: "Benitec Biopharma Inc."
filed_at: "2023-08-11T23:59:59+00:00"
generated_at: "2026-06-11T15:02:23.558773+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Benitec Biopharma raises ~$30.9M gross in underwritten public offering; Series 2 warrants exercise price reset to $1.93

## Summary
- Offering included 875,949 common shares, 15.1M pre-funded warrants, 16.0M common warrants; net proceeds ~$28.3M.
- Combined purchase price $1.93 per share/warrant unit; common warrants exercisable at $3.86 for 5 years.
- Exercise price of 29.8M outstanding Series 2 warrants automatically reset from $11.22 to $1.93 due to offering.
- Proceeds to support clinical development of BB-301 (Phase 1b/2a natural history and treatment studies) and other programs.

## SEC filing metadata
- accession: 0001193125-23-210679
- form_type: 8-K
- ticker: BNTC
- cik: 0001808898
- company_name: Benitec Biopharma Inc.
- filed_at: 2023-08-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808898/000119312523210679/0001193125-23-210679-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808898/000119312523210679/d518652d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-210679
- JSON: https://secwatch.observer/filing/0001193125-23-210679.json
- Plain text: https://secwatch.observer/filing/0001193125-23-210679.txt

## Key facts
- Material Agreements
  Benitec Biopharma Inc. entered into Underwriting Agreement with Citizens JMP Securities, LLC valued at approximately $28.3 million (effective 2023-08-08).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Citizens JMP Securities, LLC
  - Value: approximately $28.3 million
  - Effective: 2023-08-08
  source text: On August 8, 2023, Benitec Biopharma Inc., a Delaware corporation (the “Company”), entered into an Underwriting Agreement (the “Underwriting Agreement”) with Citizens JMP Securities, LLC (the “Underwriter”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808898/000119312523210679/0001193125-23-210679-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.